Italy
· Delayed Price · Currency is EUR BIT: REC Statistics
Total Valuation
Recordati Industria Chimica e Farmaceutica has a market cap or net worth of EUR 10.31 billion. The enterprise value is 11.64 billion.
| Market Cap | 10.31B |
| Enterprise Value | 11.64B |
Important Dates
The next estimated earnings date is Friday, February 21, 2025.
| Earnings Date | Feb 21, 2025 |
| Ex-Dividend Date | Nov 18, 2024 |
Share Statistics
Recordati Industria Chimica e Farmaceutica has 204.48 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 204.48M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 22.52% |
| Float | 96.10M |
Valuation Ratios
The trailing PE ratio is 24.91 and the forward PE ratio is 20.84. Recordati Industria Chimica e Farmaceutica's PEG ratio is 1.94.
| PE Ratio | 24.91 |
| Forward PE | 20.84 |
| PS Ratio | 4.58 |
| PB Ratio | 5.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 20.74 |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.94 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.70, with an EV/FCF ratio of 23.43.
| EV / Earnings | 27.52 |
| EV / Sales | 5.13 |
| EV / EBITDA | 13.70 |
| EV / EBIT | 16.67 |
| EV / FCF | 23.43 |
Financial Position
The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.84.
| Current Ratio | 1.38 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.84 |
| Debt / EBITDA | 1.85 |
| Debt / FCF | 3.16 |
| Interest Coverage | 8.61 |
Financial Efficiency
Return on equity (ROE) is 23.50% and return on invested capital (ROIC) is 12.47%.
| Return on Equity (ROE) | 23.50% |
| Return on Assets (ROA) | 10.35% |
| Return on Capital (ROIC) | 12.47% |
| Revenue Per Employee | 509,369 |
| Profits Per Employee | 94,977 |
| Employee Count | 4,455 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 1.64 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.02% in the last 52 weeks. The beta is 0.40, so Recordati Industria Chimica e Farmaceutica's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +5.02% |
| 50-Day Moving Average | 51.98 |
| 200-Day Moving Average | 50.75 |
| Relative Strength Index (RSI) | 41.26 |
| Average Volume (20 Days) | 290,177 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Recordati Industria Chimica e Farmaceutica had revenue of EUR 2.27 billion and earned 423.12 million in profits. Earnings per share was 2.02.
| Revenue | 2.27B |
| Gross Profit | 1.60B |
| Operating Income | 698.45M |
| Pretax Income | 543.12M |
| Net Income | 423.12M |
| EBITDA | 837.18M |
| EBIT | 698.45M |
| Earnings Per Share (EPS) | 2.02 |
Balance Sheet
The company has 235.02 million in cash and 1.57 billion in debt, giving a net cash position of -1.34 billion or -6.54 per share.
| Cash & Cash Equivalents | 235.02M |
| Total Debt | 1.57B |
| Net Cash | -1.34B |
| Net Cash Per Share | -6.54 |
| Equity (Book Value) | 1.88B |
| Book Value Per Share | 9.10 |
| Working Capital | 348.91M |
Cash Flow
In the last 12 months, operating cash flow was 530.40 million and capital expenditures -33.43 million, giving a free cash flow of 496.97 million.
| Operating Cash Flow | 530.40M |
| Capital Expenditures | -33.43M |
| Free Cash Flow | 496.97M |
| FCF Per Share | 2.43 |
Margins
Gross margin is 70.63%, with operating and profit margins of 30.78% and 18.65%.
| Gross Margin | 70.63% |
| Operating Margin | 30.78% |
| Pretax Margin | 23.93% |
| Profit Margin | 18.65% |
| EBITDA Margin | 36.89% |
| EBIT Margin | 30.78% |
| FCF Margin | 21.90% |
Dividends & Yields
This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 2.38%.
| Dividend Per Share | 1.20 |
| Dividend Yield | 2.38% |
| Dividend Growth (YoY) | 5.13% |
| Years of Dividend Growth | 11 |
| Payout Ratio | 58.40% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 2.37% |
| Earnings Yield | 4.01% |
| FCF Yield | 4.82% |
Stock Splits
The last stock split was on April 18, 2005. It was a forward split with a ratio of 4.
| Last Split Date | Apr 18, 2005 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Recordati Industria Chimica e Farmaceutica has an Altman Z-Score of 4.51.
| Altman Z-Score | 4.51 |
| Piotroski F-Score | n/a |